Pirjo Maarit Laakkonen

All papers authored by Pirjo Maarit Laakkonen

This paper is made freely available by the publisher.

2024 Pyry Dillemuth, Tuomas Karskela, Abiodun Ayo, Jesse Ponkamo, Jonne Kunnas, Johan Rajander, Olli Tynninen, Anne Roivainen, Pirjo Laakkonen

, Anu J. Airaksinen, Xiang-Guo Li

Radiosynthesis, structural identification and in vitro tissue binding study of [18F]FNA-S-ACooP, a novel radiopeptide for targeted PET imaging of fatty acid binding protein 3

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Negar Pourjamal

, Narjes Yazdi, Aleksi Halme, Vadim Le Joncour, Pirjo Laakkonen

, Pipsa Saharinen, Heikki Joensuu, Mark Barok

Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis model

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2023 Hector J. Monzo, Kerttu Kalander, Marko M. Hyytiäinen, Endrit Elbasani, Johanna Wall, Lidia Moyano-Galceran, Jayendrakishore Tanjore Ramanathan, Joonas Jukonen, Pirjo Laakkonen

, Ari Ristimäki, Joseph W. Carlson, Kaisa Lehti, Sahar Salehi, Pauli Puolakkainen, Caj Haglund and 3 other authors

Supplementary Figure S7 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Upload

Hector J. Monzo, Kerttu Kalander, Marko M. Hyytiäinen, Endrit Elbasani, Johanna Wall, Lidia Moyano-Galceran, Jayendrakishore Tanjore Ramanathan, Joonas Jukonen, Pirjo Laakkonen

, Ari Ristimäki, Joseph W. Carlson, Kaisa Lehti, Sahar Salehi, Pauli Puolakkainen, Caj Haglund and 3 other authors

Supplementary Figure S1 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Upload

Hector J. Monzo, Kerttu Kalander, Marko M. Hyytiäinen, Endrit Elbasani, Johanna Wall, Lidia Moyano-Galceran, Jayendrakishore Tanjore Ramanathan, Joonas Jukonen, Pirjo Laakkonen

, Ari Ristimäki, Joseph W. Carlson, Kaisa Lehti, Sahar Salehi, Pauli Puolakkainen, Caj Haglund and 3 other authors

Supplementary Figure S6 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Upload

Hector J. Monzo, Kerttu Kalander, Marko M. Hyytiäinen, Endrit Elbasani, Johanna Wall, Lidia Moyano-Galceran, Jayendrakishore Tanjore Ramanathan, Joonas Jukonen, Pirjo Laakkonen

, Ari Ristimäki, Joseph W. Carlson, Kaisa Lehti, Sahar Salehi, Pauli Puolakkainen, Caj Haglund and 3 other authors

Supplementary Figure S3 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Upload

Hector J. Monzo, Kerttu Kalander, Marko M. Hyytiäinen, Endrit Elbasani, Johanna Wall, Lidia Moyano-Galceran, Jayendrakishore Tanjore Ramanathan, Joonas Jukonen, Pirjo Laakkonen

, Ari Ristimäki, Joseph W. Carlson, Kaisa Lehti, Sahar Salehi, Pauli Puolakkainen, Caj Haglund and 3 other authors

Supplementary Figure S2 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Upload

Hector J. Monzo, Kerttu Kalander, Marko M. Hyytiäinen, Endrit Elbasani, Johanna Wall, Lidia Moyano-Galceran, Jayendrakishore Tanjore Ramanathan, Joonas Jukonen, Pirjo Laakkonen

, Ari Ristimäki, Joseph W. Carlson, Kaisa Lehti, Sahar Salehi, Pauli Puolakkainen, Caj Haglund and 3 other authors

Supplementary table S1 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Upload

Hector J. Monzo, Kerttu Kalander, Marko M. Hyytiäinen, Endrit Elbasani, Johanna Wall, Lidia Moyano-Galceran, Jayendrakishore Tanjore Ramanathan, Joonas Jukonen, Pirjo Laakkonen

, Ari Ristimäki, Joseph W. Carlson, Kaisa Lehti, Sahar Salehi, Pauli Puolakkainen, Caj Haglund and 3 other authors

Supplementary Figure Legends from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Upload

Hector J. Monzo, Kerttu Kalander, Marko M. Hyytiäinen, Endrit Elbasani, Johanna Wall, Lidia Moyano-Galceran, Jayendrakishore Tanjore Ramanathan, Joonas Jukonen, Pirjo Laakkonen

, Ari Ristimäki, Joseph W. Carlson, Kaisa Lehti, Sahar Salehi, Pauli Puolakkainen, Caj Haglund and 3 other authors

Supplementary Figure S5 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Upload

Hector J. Monzo, Kerttu Kalander, Marko M. Hyytiäinen, Endrit Elbasani, Johanna Wall, Lidia Moyano-Galceran, Jayendrakishore Tanjore Ramanathan, Joonas Jukonen, Pirjo Laakkonen

, Ari Ristimäki, Joseph W. Carlson, Kaisa Lehti, Sahar Salehi, Pauli Puolakkainen, Caj Haglund and 3 other authors

Supplementary Figure S4 from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Upload

Hector J. Monzo, Kerttu Kalander, Marko M. Hyytiäinen, Endrit Elbasani, Johanna Wall, Lidia Moyano-Galceran, Jayendrakishore Tanjore Ramanathan, Joonas Jukonen, Pirjo Laakkonen

, Ari Ristimäki, Joseph W. Carlson, Kaisa Lehti, Sahar Salehi, Pauli Puolakkainen, Caj Haglund and 3 other authors

Supplementary Data S1. from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Upload

Hector J. Monzo, Kerttu Kalander, Marko M. Hyytiäinen, Endrit Elbasani, Johanna Wall, Lidia Moyano-Galceran, Jayendrakishore Tanjore Ramanathan, Joonas Jukonen, Pirjo Laakkonen

, Ari Ristimäki, Joseph W. Carlson, Kaisa Lehti, Sahar Salehi, Pauli Puolakkainen, Caj Haglund and 3 other authors

Data from Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Upload

Jayendrakishore Tanjore Ramanathan, Tomáš Zárybnický, Pauliina Filppu, Hector J. Monzo, Outi Monni, Topi A. Tervonen, Juha Klefström, Laura Kerosuo, Satu Kuure, Pirjo Laakkonen

Immunoglobulin superfamily member 3 is required for the vagal neural crest cell migration and enteric neuronal network organization

Download from doi.org

Monzo Hj, Hector J. Monzo

, Kerttu Kalander

, Marko M. Hyytiäinen

, Endrit Elbasani

, Johanna Wall

, Lidia Moyano-Galceran

, Jayendrakishore Tanjore Ramanathan

, Joonas Jukonen

, Pirjo Laakkonen

, Ari Ristimäki

, Joseph W. Carlson

, Carlson Jw, Kaisa Lehti

, Sahar Salehi

and 6 other authors

Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model

Upload

Vadim Le Joncour, Ana Martins, Maija Puhka, Jorma Isola, Marko Salmikangas, Pirjo Laakkonen

, Heikki Joensuu, Mark Barok

methods_8.pdf from A Novel Anti-HER2 Antibody–Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine

Upload

Vadim Le Joncour, Ana Martins, Maija Puhka, Jorma Isola, Marko Salmikangas, Pirjo Laakkonen

, Heikki Joensuu, Mark Barok

Data from A Novel Anti-HER2 Antibody–Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine

Upload

Vadim Le Joncour, Ana Martins, Maija Puhka, Jorma Isola, Marko Salmikangas, Pirjo Laakkonen

, Heikki Joensuu, Mark Barok

Supplementary Data from A Novel Anti-HER2 Antibody–Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine

Upload

Krista Tuohinto, Terri A. DiMaio, Elina A. Kiss, Pirjo Laakkonen

, Pipsa Saharinen, Tara Karnezis, Michael Lagunoff

, Päivi M. Ojala

KSHV infection of endothelial precursor cells with lymphatic characteristics as a novel model for translational Kaposi’s sarcoma studies

Download from doi.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Pirjo Maarit Laakkonen